News from us and our partners

Tags

Topics

0 results

News
3 January, 2023
MaxCyte signs strategic platform license with Catamaran Bio to support its CAR-NK cell therapy programs
News
22 December, 2022
Lilly and ProQR to expand RNA editing collaboration
News
20 December, 2022
Elicit Plant awarded up to €7.5 M funding from the European Commission through the EIC Accelerator program for deep tech start-ups
News
20 December, 2022
May Health completes treatment of five participants in U.S. feasibility study of its Ovarian Rebalancing treatment for PCOS-related infertility
News
20 December, 2022
AAVantgarde Founder and Chief Scientific Officer, Professor Alberto Auricchio, is elected as Vice President of the European Society of Gene and Cell Therapy
News
19 December, 2022
First U.S. patient successfully treated with Pi-Cardia’s ShortCut(TM)
News
19 December, 2022
EnginZyme raises €21 million in Series B to accelerate the commercialisation of its cell-free biomanufacturing technology
News
19 December, 2022
F2G announces FDA filing acceptance of New Drug Application for olorofim for the treatment of invasive fungal Infections
News
15 December, 2022
Pixium Vision announces completion of implantations in the European pivotal trial PRIMAvera and confirms target read-out around the end of 2023 and regulatory submission in Europe in H1 2024
News
13 December, 2022
Moon Surgical completes first-in-human clinical study with its Maestro™ Surgical Robotics System
News
13 December, 2022
Calliditas Therapeutics announces license agreement with Viatris to register and commercialize specialty therapy for IgA nephropathy in Japan
News
11 December, 2022
HitGen announces research agreement with Nitrase Therapeutics focused on DNA-encoded library based drug discovery
News
6 December, 2022
Moon Surgical receives first FDA 510(k) clearance for its Maestro(TM) Surgical Robotics System
News
6 December, 2022
FMC Corporation and Micropep Technologies announce strategic collaboration to co-develop bioherbicide solutions
News
29 November, 2022
Microphyt raises €15 million to accelerate the commercialization of its microalgae-based natural solutions for nutrition and well-being
News
28 November, 2022
CinCor Pharma announces topline data for Phase 2 HALO Trial evaluating selective aldosterone synthase inhibitor baxdrostat in uncontrolled hypertension

MaxCyte signs strategic platform license with Catamaran Bio to support its CAR-NK cell therapy programs

Lilly and ProQR to expand RNA editing collaboration

Elicit Plant awarded up to €7.5 M funding from the European Commission through the EIC Accelerator program for deep tech start-ups

May Health completes treatment of five participants in U.S. feasibility study of its Ovarian Rebalancing treatment for PCOS-related infertility

AAVantgarde Founder and Chief Scientific Officer, Professor Alberto Auricchio, is elected as Vice President of the European Society of Gene and Cell Therapy

First U.S. patient successfully treated with Pi-Cardia’s ShortCut(TM)

EnginZyme raises €21 million in Series B to accelerate the commercialisation of its cell-free biomanufacturing technology

F2G announces FDA filing acceptance of New Drug Application for olorofim for the treatment of invasive fungal Infections

Pixium Vision announces completion of implantations in the European pivotal trial PRIMAvera and confirms target read-out around the end of 2023 and regulatory submission in Europe in H1 2024

Moon Surgical completes first-in-human clinical study with its Maestro™ Surgical Robotics System

Calliditas Therapeutics announces license agreement with Viatris to register and commercialize specialty therapy for IgA nephropathy in Japan

HitGen announces research agreement with Nitrase Therapeutics focused on DNA-encoded library based drug discovery

Moon Surgical receives first FDA 510(k) clearance for its Maestro(TM) Surgical Robotics System

FMC Corporation and Micropep Technologies announce strategic collaboration to co-develop bioherbicide solutions

Microphyt raises €15 million to accelerate the commercialization of its microalgae-based natural solutions for nutrition and well-being

CinCor Pharma announces topline data for Phase 2 HALO Trial evaluating selective aldosterone synthase inhibitor baxdrostat in uncontrolled hypertension